R Squared’s Colgate-Palmolive CL Stock Holding History

R Squared’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,240	Closed	-$899K	–	555
2025 Q3	$899K	Buy	11,240 +7,445	+196%	+$635K	0.39%	53
2025 Q2	$345K	Sell	3,795 -2,045	-35%	-$187K	0.19%	182
2025 Q1	$547K	Buy	5,840 +4,030	+223%	+$361K	0.58%	42
2024 Q4	$165K	Buy	+1,810	New	+$173K	0.16%	150

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

R Squared's CL Position: Q4 2025 in Review

R Squared sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 11,240 shares — an estimated $899K sold.

R Squared first reported a position in CL in Q4 2024 and held it in 4 quarters. The position peaked at $899K in Q3 2025. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

R Squared reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
R Squared sold 11,240 Colgate-Palmolive shares in Q4 2025, an estimated $899K.
R Squared first reported a position in Colgate-Palmolive in Q4 2024 and held it in 4 quarters.
R Squared's Colgate-Palmolive position peaked at $899K in Q3 2025.
1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on R Squared's 13F filing for Q4 2025, filed 30 Jan 2026.